Recent advances in the development of cyclin-dependent kinase 7 inhibitors
Clicks: 487
ID: 121460
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
30.0
/100
487 views
62 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #15 of 406 articles by views in European journal of medicinal chemistry
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 406 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Cyclin dependent kinase 7 (CDK7) plays a double role as it activates several other cyclin dependent kinases and participates to the initiation of transcription. This kinase is overexpressed in various types of tumors. Relatively few selective CDK7 inhibitors have been up to now disclosed. Most of th …
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (46 words).
Try re-searching for a better abstract.
| Reference Key |
y2019europeanrecent
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Teng Y;Lu K;Zhang Q;Zhao L;Huang Y;Ingarra AM;Galons H;Li T;Cui S;Yu P;Oumata N;; |
| Journal | European journal of medicinal chemistry |
| Year | 2019 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
Tumor
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
review
animals
humans
pubmed abstract
nih
national institutes of health
national library of medicine
cell line
cell survival / drug effects
protein kinase inhibitors / pharmacology
pmid:31514062
doi:10.1016/j.ejmech.2019.111641
yuou teng
kui lu
nassima oumata
antineoplastic agents / chemistry*
antineoplastic agents / pharmacology
cyclin-dependent kinases / antagonists & inhibitors*
drug development
protein kinase inhibitors / chemistry*
pyrimidines / chemistry*
pyrimidines / pharmacology
triazines / chemistry*
triazines / pharmacology
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.